Drugs News and Research

RSS

UAB professors honored for scientific contributions and outstanding mentorship

Three University of Alabama at Birmingham (UAB) professors have been elected fellows of the American Association for the Advancement of Science (AAAS).

18 Dec 2009

Cost of Avastin a deterrent for non-small-cell lung cancer treatment

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the cost of Roche/Chugai's Avastin, followed by concerns about its efficacy and side-effect profile, are cited most frequently by surveyed oncologists as the factors preventing their use of Avastin for non-small-cell lung cancer treatment in Germany, France, Italy, Spain and the United Kingdom.

18 Dec 2009

Human protein may help prevent H1N1 infection

Howard Hughes Medical Institute researchers have identified a naturally occurring human protein that helps prevent infection by H1N1 influenza and other viruses, including West Nile and dengue virus.

18 Dec 2009

AHF praises California Assembly members' initiative to protect state’s AIDS drug program funding

AIDS Healthcare Foundation (AHF) today praised the action taken by thirty-eight members of the California Assembly who, in a signed letter, urged Governor Schwarzenegger to protect funding for California’s AIDS Drug Assistance Program (ADAP). The Governor, who is currently completing his 2010-11 budget, could propose up to $70 million in cuts to ADAP in his upcoming budget, a move which, if enacted, will gut the state’s lifesaving AIDS drug program currently serving more than 35,000 low-income Californians living with HIV/AIDS.

18 Dec 2009

FDA advisory committee votes against approval of Tarceva for lung cancer treatment

Yesterday, an advisory committee to the Food and Drug Administration voted against the approval of Tarceva(R) (erlotinib) as maintenance treatment for advanced lung cancer patients.

18 Dec 2009

JDRF to work with Johnson & Johnson to develop drug targets and pathways for treating diabetes

The Juvenile Diabetes Research Foundation, a leader in setting the agenda for diabetes research worldwide, said today that it will begin working with The Johnson & Johnson Corporate Office of Science and Technology, and its affiliates, to speed the development of drug targets and pathways to promote the survival and function of insulin-producing cells in people who have diabetes.

18 Dec 2009

Treprostinil drug reduces breathlessness in PAH patients, says study

Patients with a rare, deadly disease that mostly affects young women felt a dramatic reduction in breathlessness using an approved drug, according to study results published online today in The Journal of Heart and Lung Transplantation.

18 Dec 2009

Four commonly used chemotherapy drugs disrupt birth of new brain cells, shows study

Researchers have developed a novel animal model showing that four commonly used chemotherapy drugs disrupt the birth of new brain cells, and that the condition could be partially reversed with the growth factor IGF-1.

18 Dec 2009

Antidepressants may play a key role in improving adolescents’ mental health

Suicidal adolescents who were prescribed an antidepressant medication during inpatient psychiatric hospital treatment were 85 percent less likely than others to be readmitted within a month after discharge, a new study found.

18 Dec 2009

Comprehensive approaches to understand the interaction of H1N1 strains with human cells

Scientists have generated hundreds of new leads in the fight against the H1N1 flu pandemic, according to two new studies published online December 17th in the journal Cell, a Cell Press publication.

18 Dec 2009

Phase 2 clinical study of STA-9090 in NSCLC initiated

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 2 clinical study of STA-9090 in non-small cell lung cancer (NSCLC).

18 Dec 2009

PRPS1 gene associated with DFN2 identified by researchers

A gene associated with a rare form of progressive deafness in males has been identified by an international team of researchers funded by the National Institute on Deafness and Other Communication Disorders.

17 Dec 2009

Switching between A-rated anti-epileptic drug formulations does not increase seizure risk

Express Scripts, Inc., one of the largest pharmacy benefit management companies in North America, announced today results of a study that examined the association of seizure risk among epilepsy patients after switching between A-rated anti-epileptic drug formulations. The study found no evidence that switching between A-rated anti-epileptic drugs, including brand to generic substitution, was associated with increased emergency room visits or hospitalizations for epilepsy.

17 Dec 2009

First Edition: December 17, 2009

Today's big story, according to the headlines, are the delays in the Senate debate.

17 Dec 2009

New offers on penis extender device during holiday season

Just in time for the holidays, Quick Extender Pro™, an industry leader in penis enlargement, is offering 25% off their penis extender device along with a free bonus holiday gift.

17 Dec 2009

Prophylactic misuse of NSAIDs cause more harm than good

Athletes' superstitions and rituals can help them get psyched up for contests, but when these rituals involve non-steroidal anti-inflammatory drugs (NSAIDs), which many athletes gobble down before and during events, they could be causing more harm than good.

17 Dec 2009

Promising breakthrough in adjuvant development may lead to cost-effective therapeutic vaccines

It should be possible to use therapeutic vaccines to create both cheap and effective drugs for diseases like cancer and allergies. One problem in developing such vaccines has previously been the lack of adjuvants, substances that make vaccines more effective. However, there has now been a major breakthrough in this area. The study, led by Swedish scientists at Uppsala University, is published in the December issue of the journal Vaccine.

17 Dec 2009

New comparison of subsidized COBRA premiums and non-group health insurance premiums

Today eHealth, Inc. released a new comparison of subsidized individual COBRA premiums and non-group health insurance premiums for individuals using data derived from eHealth's December 2009 Cost and Benefits Report and a Families USA Foundation report released in January 2009.

17 Dec 2009

Human embryonic stem cell lines lack genetic diversity, says study

The most widely used human embryonic stem cell lines lack genetic diversity, a finding that raises social justice questions that must be addressed to ensure that all sectors of society benefit from stem cell advances, according to a University of Michigan research team.

17 Dec 2009

Sanofi Pasteur uses PHT’s LogPad System and StudyWorks online portal for its Phase II trial

PHT Corporation announced that Sanofi Pasteur is using PHT’s LogPad® System and StudyWorksTM online portal for a Phase II trial to develop a vaccine against the Clostridium difficile bacterium.

17 Dec 2009

Drugs News and Research

UAB professors honored for scientific contributions and outstanding mentorship

Cost of Avastin a deterrent for non-small-cell lung cancer treatment

Human protein may help prevent H1N1 infection

AHF praises California Assembly members' initiative to protect state’s AIDS drug program funding

FDA advisory committee votes against approval of Tarceva for lung cancer treatment

JDRF to work with Johnson & Johnson to develop drug targets and pathways for treating diabetes

Treprostinil drug reduces breathlessness in PAH patients, says study

Four commonly used chemotherapy drugs disrupt birth of new brain cells, shows study

Antidepressants may play a key role in improving adolescents’ mental health

Comprehensive approaches to understand the interaction of H1N1 strains with human cells

Phase 2 clinical study of STA-9090 in NSCLC initiated

PRPS1 gene associated with DFN2 identified by researchers

Switching between A-rated anti-epileptic drug formulations does not increase seizure risk

First Edition: December 17, 2009

New offers on penis extender device during holiday season

Prophylactic misuse of NSAIDs cause more harm than good

Promising breakthrough in adjuvant development may lead to cost-effective therapeutic vaccines

New comparison of subsidized COBRA premiums and non-group health insurance premiums

Human embryonic stem cell lines lack genetic diversity, says study

Sanofi Pasteur uses PHT’s LogPad System and StudyWorks online portal for its Phase II trial

Drug Discovery - Second Edition eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News